Delia*s, Inc. (DLIA) Reports Q3 Loss of $0.14, Sales Fall 4.2% Y/Y
Tweet
Share
E-mailGet Alerts DLIA Hot Sheet
Price: $0.01 --0%
Financial Fact:
Other operating income: -214K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Other operating income: -214K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Delia*s, Inc. (NASDAQ: DLIA) reported Q3 EPS of ($0.14), $0.04 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $58.1 million versus the consensus estimate of $59.5 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
- zSpace, Inc. (ZSPC) Reports Q2 results
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
